Viberzi (ALLERGAN USA, INC.)
Welcome to the PulseAid listing for the Viberzi drug offered from ALLERGAN USA, INC.. This mu-Opioid Receptor Agonist [EPC],Opioid mu-Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | ALLERGAN USA, INC. |
NON-PROPRIETARY NAME: | Eluxadoline |
SUBSTANCE NAME: | ELUXADOLINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | mu-Opioid Receptor Agonist [EPC],Opioid mu-Receptor Agonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-10-01 |
END MARKETING DATE: | 0000-00-00 |
Viberzi HUMAN PRESCRIPTION DRUG Details:
Item Description | Viberzi from ALLERGAN USA, INC. |
LABELER NAME: | ALLERGAN USA, INC. |
DEA SCHEDULE: | CIV
|
ACTIVE STRENGTH: | 75(mg/1) |
START MARKETING DATE: | 2015-10-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61874-075_c116624b-c190-4119-ab69-900d12b9795f |
PRODUCT NDC: | 61874-075 |
APPLICATION NUMBER: | NDA206940 |
Other ELUXADOLINE Pharmaceutical Manufacturers / Labelers: